KinoPharma Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series E
- Investors
-
19
KinoPharma General Information
Description
Developer of molecule drugs designed to provide antiviral medication to women for papillomavirus (HPV) infection. The company's research responds to the discovery and clinical development of next-generation antifungal remedies using an approach different from conventional antibacterial medicine strategies, enabling women to treat cervical cancer before it develops.
Contact Information
Website
www.kinopharma.comCorporate Office
- 705 Nihonbashi Life Science Building 2
- 3-11-5 Nihonbashi Honcho, Chuo-ku
- Tokyo, 103-0023
- Japan
Corporate Office
- 705 Nihonbashi Life Science Building 2
- 3-11-5 Nihonbashi Honcho, Chuo-ku
- Tokyo, 103-0023
- Japan
KinoPharma Timeline
KinoPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series E) | 28-Feb-2025 | Completed | Clinical Trials - Phase 2 | |||
| 11. Later Stage VC | 31-Jul-2023 | Completed | Clinical Trials - Phase 2 | |||
| 10. Secondary Transaction - Private | 01-Mar-2023 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC (Series D) | 10-Dec-2021 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC | 31-Mar-2020 | Completed | Startup | |||
| 7. Later Stage VC | Completed | Startup | ||||
| 6. Later Stage VC | Completed | Startup | ||||
| 5. Later Stage VC | Completed | Startup | ||||
| 4. Later Stage VC | 14-Sep-2018 | $9M | $9.6M | Completed | Startup | |
| 3. Later Stage VC | 27-Dec-2016 | $605K | $605K | Completed | Startup |
KinoPharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class G | ||||||||
| Class F | ||||||||
| Class E | ||||||||
| Class D | ||||||||
| Class C | ||||||||
| Class B | 300 | $2125.61 | $2125.61 | 1x | $2125.61 | 4.38% | ||
| Class A | 700 | $708.54 | $708.54 | 1x | $708.54 | 10.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
KinoPharma Patents
KinoPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4520330-A1 | Aniline-derivative-containing external agent for skin | Pending | 02-May-2022 | ||
| EP-4520330-A4 | Aniline-derivative-containing external agent for skin | Pending | 02-May-2022 | ||
| WO-2023214568-A1 | Aniline-derivative-containing external agent for skin | Inactive | 02-May-2022 | ||
| AU-2023265202-A1 | Aniline-derivative-containing external preparation for skin | Pending | 02-May-2022 | ||
| US-20250339420-A1 | Aniline-derivative-containing external preparation for skin | Pending | 02-May-2022 | A61K31/4545 |
KinoPharma Signals
KinoPharma Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AirTrip | Corporation | Minority | ||
| Awagin Capital | PE/Buyout | Minority | ||
| Iwagin Jigyo Souzou Capital | Venture Capital | Minority | ||
| Kyoshin Social Capital | Corporate Venture Capital | Minority | ||
| NCB Capital (Fukuoka) | Corporate Venture Capital | Minority |
KinoPharma FAQs
-
When was KinoPharma founded?
KinoPharma was founded in 2005.
-
Where is KinoPharma headquartered?
KinoPharma is headquartered in Tokyo, Japan.
-
What is the size of KinoPharma?
KinoPharma has 10 total employees.
-
What industry is KinoPharma in?
KinoPharma’s primary industry is Drug Discovery.
-
Is KinoPharma a private or public company?
KinoPharma is a Private company.
-
What is KinoPharma’s current revenue?
The current revenue for KinoPharma is .
-
How much funding has KinoPharma raised over time?
KinoPharma has raised $29.9M.
-
Who are KinoPharma’s investors?
AirTrip, Awagin Capital, Iwagin Jigyo Souzou Capital, Kyoshin Social Capital, and NCB Capital (Fukuoka) are 5 of 19 investors who have invested in KinoPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process